Ribosome-Inactivating Proteins: From Plant Toxins to Drug Applications
A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Plant Toxins".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 255
Special Issue Editor
Interests: lectins; toxicity; ribosome-inactivating proteins; proteins as drug targets
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Ribosome-inactivating proteins are proteins that act on the cellular translation mechanism of cells. They have been classified according to their structure or their mechanism for carrying out their activity when they come into contact with a cell. Their applicability in the biomedical field is related to the selectivity of the target cell. Among the obstacles for the use of RIPs in the treatment of cancer or diseases where viruses are the protagonists are their short half-life in the cytoplasm, non-selective cytotoxicity and antigenicity. Therefore, strategies have been developed to improve the pharmacological properties of RIPs. These strategies include the combination of these proteins with antibodies, increasing their plasma life with polyethylene glycol, creating peptide or protein subunit nanoparticles with antibodies or forming a part of drugs using nanotechnologies.
This Special Issue aims to highlight the use of RIPs in the biomedical field, to describe their physiological and pathological characteristics and effects, as well as their applicability in nutrition and medicine.
Prof. Dr. Maria Angeles Rojo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- plant toxins
- ribosome-inactivating proteins (RIPs)
- targeted therapy
- ricin
- lectins
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
